William Blair：2026年人工智能如何改写药物开发经济学报告（英文版）

Here is the short version:AI is not replacing the physical work of drug discovery,but it is reshaping it. It is true that AI is increasingly being leveraged as a“dry lab” (i.e., computational) tool for hypothesis generation, but those hypotheses will always need to be physically tested in the“wet lab”(i.e., the real world) and the overwhelming majority of drug discovery spend relates to the work of proving what’s true in the real world. Hence, the“wet lab obsolescence” narrative is overstated